Immunotherapy in the resectable NSCLC setting: learnings from patient cases

Live webinar from ESMO in Madrid

Sunday 22^nd October
20:00 - 21:30

Immunotherapy (in combination or as monotherapy) has gained a lot of importance in the treatment of metastatic non-small cell lung cancer (NSCLC) patients, and has even become the standard of care for most if not all of them. More recent data and developments have now also brought immunotherapy to earlier stages of the disease, amongst which the resectable NSCLC setting. This live webinar (and already the 8th edition of the ECLIPSE educational webinar series) will focus on sharing experiences with immunotherapy in this resectable NSCLC setting from both the pneumo-oncologist AND thoracic surgeon’s perspective. Patient cases will be presented and there will be room for Q&A and a panel discussion with the experts towards the end of the meeting.